First Terbinafine-Resistant Trichophyton indotineae Isolates with Phe397Leu and/or Thr414His Mutations in Turkey

Murat Durdu1, Hazal Kandemir2, Ayşe Sultan Karakoyun3

  • 1Department of Dermatology, Adana Dr. Turgut Noyan Application and Research Center, Başkent University Faculty of Medicine, Adana, Turkey. sivandr@hotmail.com.

Mycopathologia
|January 19, 2023
PubMed

Insights

Two cases of terbinafine-resistant Trichophyton indotineae, a fungal infection, were reported in Turkey. Resveratrol showed clinical improvement in one patient with a CD36 mutation, highlighting potential new treatment avenues.

Area of Science:

  • Medical Mycology
  • Dermatology
  • Infectious Diseases

Background:

  • Superficial dermatophytosis, fungal skin infections, are a global health issue.
  • Increasing resistance to terbinafine, a common antifungal, is a growing clinical concern.
  • Trichophyton indotineae is an emerging cause of terbinafine-resistant fungal infections.

Purpose of the Study:

  • To report the first cases of Trichophyton indotineae infection in Turkey.
  • To investigate the clinical presentation and genetic basis of terbinafine resistance in these cases.
  • To evaluate the efficacy of resveratrol as a potential treatment.

Main Methods:

  • Case report of two patients with terbinafine-resistant fungal infections.
  • Identification of the causative fungal species (Trichophyton indotineae).
  • Genetic analysis including CD36 mutation screening and squalene epoxidase gene sequencing.

Main Results:

  • The first diagnosis of Trichophyton indotineae in Turkey is presented.
  • One patient had a CD36 mutation; both strains shared an amino acid substitution in squalene epoxidase.
  • Resveratrol treatment led to clinical improvement in the patient with the CD36 mutation.

Conclusions:

  • Trichophyton indotineae is an emerging pathogen causing terbinafine-resistant dermatophytosis in Turkey.
  • CD36 mutation may play a role in terbinafine resistance and response to resveratrol.
  • Further research is needed to understand the mechanisms of resistance and explore novel therapies.